Free Trial

Sensei Biotherapeutics (SNSE) Short Interest Ratio & Short Volume

Sensei Biotherapeutics logo
$9.14 -0.13 (-1.36%)
As of 07/3/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Sensei Biotherapeutics Short Interest Data

Sensei Biotherapeutics (SNSE) has a short interest of 4,500 shares, representing 0.54% of the float (the number of shares available for trading by the public). This marks a -93.54% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 45,684 shares to cover all short positions.

Current Short Interest
4,500 shares
Previous Short Interest
69,700 shares
Change Vs. Previous Month
-93.54%
Dollar Volume Sold Short
$27.00 thousand
Short Interest Ratio
0.0 Days to Cover
Last Record Date
June 15, 2025
Outstanding Shares
1,260,000 shares
Float Size
825,900 shares
Short Percent of Float
0.54%
Today's Trading Volume
5,809 shares
Average Trading Volume
45,684 shares
Today's Volume Vs. Average
13%
Short Selling Sensei Biotherapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Sensei Biotherapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

SNSE Short Interest Over Time

SNSE Days to Cover Over Time

SNSE Percentage of Float Shorted Over Time

Sensei Biotherapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/15/20254,500 shares $27.00 thousand -93.5%0.5%0 $6.00
5/31/202569,700 shares $21.40 thousand -64.7%0.4%0 $0.31
5/15/2025197,200 shares $68.63 thousand -50.5%1.2%0.1 $0.35
4/30/2025398,100 shares $160.43 thousand -24.0%2.4%0.2 $0.40
4/15/2025523,700 shares $239.85 thousand -72.6%3.2%0.2 $0.46
3/31/20251,910,000 shares $752.54 thousand +1,478.5%11.6%0.7 $0.39
3/15/2025121,000 shares $54.57 thousand -17.5%0.7%0.4 $0.45
2/28/2025146,700 shares $68.36 thousand -14.1%0.9%0.4 $0.47
2/15/2025170,700 shares $81.25 thousand -36.0%1.0%0.4 $0.48
1/31/2025266,500 shares $125.26 thousand -64.8%1.6%0.6 $0.47
1/15/2025757,800 shares $384.89 thousand +594.0%4.6%1.5 $0.51
12/31/2024109,200 shares $53.52 thousand +30.5%0.7%0.2 $0.49
12/15/202483,700 shares $36.83 thousand -63.1%0.5%0.2 $0.44
11/30/2024226,700 shares $122.64 thousand +13.2%1.4%0.5 $0.54
11/15/2024200,300 shares $90.84 thousand +2.9%1.2%0.5 $0.45
10/31/2024194,700 shares $92.44 thousand -12.8%1.2%0.6 $0.47
10/15/2024223,200 shares $103.79 thousand -12.4%1.4%0.9 $0.47
9/30/2024254,800 shares $152.37 thousand +1.7%1.5%4.9 $0.60
9/15/2024250,600 shares $135.32 thousand -5.2%1.5%5.4 $0.54
8/31/2024264,400 shares $160.17 thousand -0.2%1.6%7.3 $0.61
8/15/2024265,000 shares $161.39 thousand -0.9%1.6%2.6 $0.61
7/31/2024267,500 shares $181.37 thousand -2.3%1.6%2 $0.68
7/15/2024273,900 shares $196.52 thousand -2.4%1.7%1.2 $0.72
6/30/2024280,600 shares $174.00 thousand -3.2%1.7%1.2 $0.62
6/15/2024289,900 shares $185.04 thousand +2.6%1.8%1.2 $0.64
5/31/2024282,600 shares $209.01 thousand +250.6%1.7%1.1 $0.74
5/15/202480,600 shares $120.09 thousand +34.1%0.5%0.4 $1.49
4/30/202460,100 shares $60.70 thousand -25.8%0.4%0.4 $1.01
4/15/202481,000 shares $81.41 thousand -48.1%0.5%1.2 $1.01
3/31/2024156,200 shares $164.01 thousand +7.1%1.0%2.5 $1.05
3/15/2024145,900 shares $147.36 thousand +4.1%0.9%2.4 $1.01
2/29/2024140,100 shares $119.09 thousand -2.1%0.9%2.5 $0.85
2/15/2024143,100 shares $112.35 thousand -11.4%0.9%2.8 $0.79
1/31/2024161,500 shares $132.43 thousand -6.5%1.0%2.7 $0.82
1/15/2024172,700 shares $132.98 thousand -14.1%1.1%2.4 $0.77
12/31/2023201,000 shares $139.09 thousand +2.3%1.2%2.9 $0.69
12/15/2023196,500 shares $129.69 thousand +31.4%1.2%3.1 $0.66
11/30/2023149,600 shares $107.71 thousand -11.4%0.9%2.8 $0.72
11/15/2023168,800 shares $102.09 thousand +25.6%1.0%3.6 $0.60
10/31/2023134,400 shares $95.56 thousand -1.9%0.8%3.1 $0.71
A grave, grave error. (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

10/15/2023137,000 shares $101.38 thousand -0.2%0.8%6.9 $0.74
9/30/2023137,200 shares $109.76 thousand -14.4%0.8%7.7 $0.80
9/15/2023160,300 shares $132.10 thousand +10.4%0.9%7.8 $0.82
8/31/2023145,200 shares $145.20 thousand -5.8%0.8%6.9 $1.00
8/15/2023154,100 shares $166.43 thousand +3.6%0.9%7.1 $1.08
7/31/2023148,800 shares $187.49 thousand -2.2%0.8%6.6 $1.26
7/15/2023152,200 shares $196.34 thousand -8.7%0.9%2.2 $1.29
6/30/2023166,700 shares $190.04 thousand +11.9%0.9%2.3 $1.14
6/15/2023149,000 shares $199.66 thousand -0.9%0.8%2 $1.34
5/31/2023150,300 shares $219.44 thousand -2.9%0.7%2 $1.46
5/15/2023154,800 shares $224.46 thousand -15.5%1.0%2 $1.45
4/30/2023183,100 shares $272.82 thousand +72.4%1.1%2.3 $1.49
4/15/2023106,200 shares $159.30 thousand -3.5%0.7%1.3 $1.50
3/31/2023110,000 shares $165 thousand -1.9%0.7%3.3 $1.50
3/15/2023112,100 shares $155.82 thousand +46.9%0.7%2.9 $1.39
2/28/202376,300 shares $119.79 thousand -3.3%0.5%1.7 $1.57
2/15/202378,900 shares $112.83 thousand +24.6%0.5%1.7 $1.43
1/31/202363,300 shares $87.99 thousand +0.6%0.4%1.2 $1.39
1/15/202362,900 shares $98.75 thousand -23.2%0.4%1.2 $1.57
12/30/202281,900 shares $122.03 thousand -30.2%0.5%1.5 $1.49
12/15/2022117,300 shares $181.82 thousand -43.8%0.7%2.2 $1.55
11/30/2022208,800 shares $296.50 thousand +14.9%1.2%4.4 $1.42
11/15/2022181,700 shares $258.01 thousand -4.5%1.1%3.9 $1.42
10/31/2022190,200 shares $275.79 thousand -12.1%1.1%4.7 $1.45
10/15/2022216,300 shares $328.78 thousand +15.3%1.3%5.9 $1.52
9/30/2022187,600 shares $290.78 thousand -1.8%1.1%5 $1.55
9/15/2022191,000 shares $383.91 thousand -0.8%1.1%2.8 $2.01
8/31/2022192,600 shares $367.87 thousand -5.7%1.1%2.3 $1.91
8/15/2022204,200 shares $453.32 thousand -1.9%1.3%1.9 $2.22
7/31/2022208,200 shares $397.66 thousand -4.7%1.3%1.7 $1.91
7/15/2022218,500 shares $450.11 thousand -11.2%1.4%1.7 $2.06
6/30/2022246,100 shares $558.65 thousand -68.6%1.6%1.8 $2.27
6/15/2022783,300 shares $1.50 million +10.5%5.0%5.6 $1.91
5/31/2022708,800 shares $1.35 million -3.1%4.5%6.9 $1.90
5/15/2022731,700 shares $1.09 million +11.1%4.7%8.6 $1.49
4/30/2022658,600 shares $1.02 million +17.9%4.2%8.9 $1.55
4/15/2022558,700 shares $1.07 million -0.6%3.6%7.8 $1.92
3/31/2022562,100 shares $1.30 million +20.2%3.6%7.8 $2.31
3/15/2022467,800 shares $1.14 million +7.4%3.0%5.6 $2.43
2/28/2022435,700 shares $1.57 million +6.7%2.8%4.9 $3.61
2/15/2022408,500 shares $1.76 million +10.6%2.5%4.6 $4.30
1/31/2022369,300 shares $1.78 million +15.1%2.3%4.2 $4.82
1/15/2022320,900 shares $1.68 million -4.1%1.9%3.8 $5.24
12/31/2021334,700 shares $1.94 million +2.3%N/A0 $5.80
12/15/2021327,300 shares $1.70 million -6.1%2.0%3.9 $5.20
11/30/2021348,400 shares $2.40 million -8.3%2.1%3.4 $6.88
11/15/2021380,100 shares $3.75 million -14.8%2.3%3.4 $9.87
10/29/2021446,000 shares $3.88 million -1.4%2.7%3.5 $8.69
10/15/2021452,400 shares $3.45 million -14.0%2.7%3.6 $7.63
9/30/2021525,900 shares $5.53 million +121.1%3.1%4.3 $10.52
A grave, grave error. (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

9/15/2021237,900 shares $2.55 million -15.8%1.4%1.8 $10.70
8/31/2021282,500 shares $3.05 million -14.7%1.7%2.7 $10.78
8/13/2021331,200 shares $2.63 million No Change2.0%3.6 $7.95

SNSE Short Interest - Frequently Asked Questions

What is Sensei Biotherapeutics' current short interest?

Short interest is the volume of Sensei Biotherapeutics shares that have been sold short but have not yet been closed out or covered. As of June 15th, investors have sold 4,500 shares of SNSE short. 0.54% of Sensei Biotherapeutics' shares are currently sold short. Learn More on Sensei Biotherapeutics' current short interest.

What is a good short interest percentage for Sensei Biotherapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.54% of Sensei Biotherapeutics' floating shares are currently sold short.

Is Sensei Biotherapeutics' short interest increasing or decreasing?

Sensei Biotherapeutics saw a drop in short interest in June. As of June 15th, there was short interest totaling 4,500 shares, a drop of 93.5% from the previous total of 69,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Sensei Biotherapeutics' float size?

Sensei Biotherapeutics currently has issued a total of 1,260,000 shares. Some of Sensei Biotherapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Sensei Biotherapeutics currently has a public float of 825,900 shares.

How does Sensei Biotherapeutics' short interest compare to its competitors?

0.54% of Sensei Biotherapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Sensei Biotherapeutics: Actinium Pharmaceuticals, Inc. (4.88%), Mural Oncology PLC (1.66%), Scilex Holding Company (8.73%), Shattuck Labs, Inc. (3.84%), Iterum Therapeutics PLC (2.99%), Annovis Bio, Inc. (14.32%), Pluri Inc. (0.71%), Karyopharm Therapeutics Inc. (25.38%), Eagle Pharmaceuticals, Inc. (0.46%), Acrivon Therapeutics, Inc. (5.05%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks.

What does it mean to sell short Sensei Biotherapeutics stock?

Short selling SNSE is an investing strategy that aims to generate trading profit from Sensei Biotherapeutics as its price is falling. SNSE shares are trading down $0.20 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Sensei Biotherapeutics?

A short squeeze for Sensei Biotherapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SNSE, which in turn drives the price of the stock up even further.

How often is Sensei Biotherapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SNSE, twice per month. The most recent reporting period available is June, 15 2025.




This page (NASDAQ:SNSE) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners